Meeting NewsVideo

VIDEO: Should SLT be the preferred first-line treatment?

NEW YORK — In her presentation at OSN New York 2019, Valerie Trubnik, MD, FACS, discusses results of the LiGHT trial, which compared selective laser trabeculoplasty and eye drop treatment for mild to moderate glaucoma.

NEW YORK — In her presentation at OSN New York 2019, Valerie Trubnik, MD, FACS, discusses results of the LiGHT trial, which compared selective laser trabeculoplasty and eye drop treatment for mild to moderate glaucoma.

    See more from OSN New York